USPSTF: Insufficient evidence regarding benefits, harms of ankle-brachial index for PAD, CVD risk

Mary M. McDermott
The U.S. Preventive Services Task Force has given a class I indication for the use of ankle-brachial index to screen patients who are asymptomatic for peripheral artery disease and CVD risk due to insufficient evidence that assessed the benefits and harms of this screening method, according to a recommendation statement published in JAMA.
The USPSTF released a draft recommendation statement in January, which gave the same indication for ankle-brachial index (ABI).
“To update its 2013 recommendation, the USPSTF reviewed the evidence on whether screening for PAD with the

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button